PubMed · 2006 · 214 citations · 13 references
MedicineCardiologyHematologyCell TherapyClinical CardiologyStem Cell BiologyCell AdministrationCellular TherapyHematopoietic Stem Cell BiologyHematopoietic Stem CellsStem Cell MobilizationAdult Hematopoietic Stem CellsAutologous Hematopoietic Stem Cell MobilizationGranulocyte Colony-stimulating Factor AdministrationGranulocyte Colony-stimulating Factor MobilizationGranulocyte-macrophage Colony-stimulating Factor MobilizationMobilization RegimensMyocardial MetabolismPeripheral Blood Stem Cell Infusion
UNLABELLED: Adult stem cell therapy is expected to improve left ventricular function in patients with myocardial infarction. Because of the low risk of arrhythmia and the maximal concentration at the target tissue, intracoronary infusion of stem cells is preferred. The aim of this study was to investigate the homing and tissue distribution of intracoronary injected peripheral hematopoietic stem cells labeled with 18F-FDG. METHODS: Seventeen patients with myocardial infarction were included as the intracoronary injection group (14 males, 3 females; age, 58 +/- 12 y). Three patients underwent intravenous stem cell injection as the intravenous injection group (3 males, 0 females; age, 50 +/- 20 y). After mobilization with granulocyte colony-stimulating factor (G-CSF), peripheral stem cells were collected by means of apheresis. 18F-FDG labeling of stem cells was performed for 40 min with gentle intermittent mixing at 37 degrees C. The mean labeling efficiency was 72% (range, 46%-95%), and 44.4-175 MBq (1.2-5 mCi) of 18F-FDG-labeled stem cells were injected via an intracoronary catheter after stenting in infarct-related arteries. PET/CT images were obtained with a 3-dimensional acquisition mode 2 h after intracoronary infusion. RESULTS: Two hours after intracoronary infusion, 1.5% (range, 0.2%-3.3%) of injected stem cells accumulated at the infarcted myocardium. Outside of the myocardium, spleen, liver, bladder, and bone marrow showed a high stem cell accumulation. The delayed image of a patient up to 20 h showed a prolonged residence of stem cells at the myocardium. Intravenous injection of stem cells showed a high initial lung uptake with no myocardial activity. CONCLUSION: We have shown that 18F-FDG-labeled stem cell PET could be used to assess the tissue distribution and to measure the amount of stem cells at a target tissue. 18F-FDG-labeled stem cell PET can be used to measure and optimize the amount of stem cells injected.
13
Bone marrow cells regenerate infarcted myocardium
Donald Orlic, Jan Kajstura, Stefano Chimenti et al. · Nature · 2001 · 5.2K citations
Autologous bone-marrow stem-cell transplantation for myocardial regeneration
Christof Stamm, Bernd Westphal, Hans‐Dieter Kleine et al. · The Lancet · 2003 · 1.4K citations
Medicine, Cardiology, Surgery +14
Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium
Israel M. Barbash, Pierre Chouraqui, Jack Baron et al. · Circulation · 2003 · 1.2K citations
Pharmacy, Cardiology, Cell Biology +16